Qiu Z H, Gijón M A, de Carvalho M S, Spencer D M, Leslie C C
Division of Basic Science, Department of Pediatrics, National Jewish Medical and Research Center, Denver, Colorado 80206, USA.
J Biol Chem. 1998 Apr 3;273(14):8203-11. doi: 10.1074/jbc.273.14.8203.
Arachidonic acid release is induced in macrophages with diverse agonists including calcium ionophores, phorbol myristate acetate (PMA), okadaic acid, and the phagocytic particle, zymosan, and correlates with activation of cytosolic phospholipase A2 (cPLA2). The role of calcium and phosphorylation of cPLA2 in regulating arachidonic acid release was investigated. Zymosan induced a rapid and transient increase in [Ca2+]i. This in itself is not sufficient to induce arachidonic acid release since ATP and platelet activating factor (PAF), agonists that induce transient calcium mobilization in macrophages, induced little arachidonic acid release. Unlike zymosan, which is a strong activator of mitogen-activated protein kinase (MAPK), ATP and PAF were weak MAPK activators and induced only a partial and transient increase in cPLA2 phosphorylation (gel shift). However, ATP or PAF together with colony stimulating factor-1 (CSF-1) synergistically stimulated arachidonic acid release. CSF-1 is a strong MAPK activator that induces a rapid and complete cPLA2 gel shift but not calcium mobilization or arachidonic acid release. Arachidonic acid release was more rapid in response to CSF-1 plus ATP or PAF than zymosan and correlated with the time course of the cPLA2 gel shift. Although low concentrations of ionomycin induced a lower magnitude of calcium mobilization than ATP, the response was more sustained resulting in arachidonic acid release. A23187 and ionomycin induced weak MAPK activation, and a partial and transient cPLA2 gel shift. The MAPK kinase inhibitor, PD 98059 suppressed A23187-induced MAPK activation and cPLA2 gel shift but had little effect on arachidonic acid release. These results indicate that in macrophages a transient increase in [Ca2+]i and sustained phosphorylation of cPLA2 can act together to promote arachidonic acid release but neither alone is sufficient. A sustained increase in calcium is sufficient for inducing arachidonic acid release. However, PMA and okadaic acid induce arachidonic acid release without increasing [Ca2+]i, although resting levels of calcium are required, suggesting alternative mechanisms of regulation.
多种激动剂可诱导巨噬细胞释放花生四烯酸,这些激动剂包括钙离子载体、佛波酯肉豆蔻酸酯乙酸酯(PMA)、冈田酸以及吞噬颗粒酵母聚糖,花生四烯酸的释放与胞质磷脂酶A2(cPLA2)的激活相关。研究了钙及cPLA2磷酸化在调节花生四烯酸释放中的作用。酵母聚糖可诱导细胞内钙离子浓度([Ca2+]i)迅速短暂升高。但仅这一点不足以诱导花生四烯酸释放,因为ATP和血小板活化因子(PAF)这两种能在巨噬细胞中诱导短暂钙动员的激动剂,几乎不诱导花生四烯酸释放。与酵母聚糖(一种丝裂原活化蛋白激酶(MAPK)的强激活剂)不同,ATP和PAF是较弱的MAPK激活剂,仅诱导cPLA2磷酸化(凝胶迁移)出现部分且短暂的增加。然而,ATP或PAF与集落刺激因子-1(CSF-1)协同刺激花生四烯酸释放。CSF-1是一种强MAPK激活剂,可诱导cPLA2迅速且完全的凝胶迁移,但不引起钙动员或花生四烯酸释放。与酵母聚糖相比,CSF-1加ATP或PAF诱导花生四烯酸释放更快,且与cPLA2凝胶迁移的时间进程相关。尽管低浓度离子霉素诱导的钙动员幅度低于ATP,但其反应更持久,从而导致花生四烯酸释放。A23187和离子霉素诱导较弱的MAPK激活以及cPLA2凝胶迁移出现部分且短暂的变化。MAPK激酶抑制剂PD 98059可抑制A23187诱导的MAPK激活和cPLA2凝胶迁移,但对花生四烯酸释放影响不大。这些结果表明,在巨噬细胞中,[Ca2+]i的短暂升高和cPLA2的持续磷酸化共同作用可促进花生四烯酸释放,但单独一项都不足以达到此效果。持续的钙升高足以诱导花生四烯酸释放。然而,PMA和冈田酸在不增加[Ca2+]i的情况下诱导花生四烯酸释放,尽管需要静息钙水平,这提示了其他调节机制。